Physician Photo

Ednan Khalid Bajwa, MD

Director, Medical Intensive Care Unit

  • Phone: 617-726-1721
Pulmonary and Critical Care Medicine
Department of Medicine


  • Critical Care Center
  • Medical Intensive Care Unit
Clinical Interests
Long-term outcome after critical illness
Acute respiratory distress syndrome (ARDS)
Boston: Massachusetts General Hospital
Medical Education
MD, New York University
Residency, Massachusetts General Hospital
Fellowship, Massachusetts General Hospital
Board Certifications
Internal Medicine, American Board of Internal Medicine
Pulmonary Disease, American Board of Internal Medicine
Critical Care Medicine, American Board of Internal Medicine
Patient Age Group
Accepting New Patients
Accepting New Patients

BiographyDr. Bajwa was born and raised in Brooklyn, New York. A graduate of Stuyvesant High School in New York City, he obtained his B.S. and M.D. degrees from New York University. He then trained in Internal Medicine at Massachusetts General Hospital, followed by subspecialty training in Pulmonary and Critical Care Medicine in the Harvard combined Pulmonary/Critical Care fellowship program. In 2007, Dr. Bajwa completed his M.P.H. degree at the Harvard School of Public Health and joined the faculty of Harvard Medical School and the Pulmonary/Critical Care Unit at Massachusetts General Hospital. Dr. Bajwa is the Director of the MGH Medical Intensive Care Unit, as well as director of the Critical Care teaching curriculum for MGH Internal Medicine residents and clerkship director for the Harvard Medical School clerkship in Intensive Care Medicine.

ResearchDr. Bajwa's primary research interest is in studying genetic susceptibility to critical illness. Specifically, he has been working for four years on the Molecular Epidemiology of the Acute Respiratory Distress Syndrome (ARDS) project, led by his research mentor Dr. David Christiani. This project has been ongoing for over 10 years and has enrolled a registry of over 4000 critically ill patients from Massachusetts General Hospital intensive care units (ICUs). The aim of this project is to describe the role of genetic variation in determining why some individuals are at greater risk than others. Dr. Bajwa's other research interests include the use of biomarkers in critical illness to further refine diagnostic and treatment strategies in the ICU, as well as ICU treatment of alcohol withdrawal.

PublicationsBajwa E, Yu C, Gong M., Thompson BT, Christiani D. Pre-B-Cell Colony-enhancing Factor gene polymorphisms and risk of Acute Respiratory Distress Syndrome. Crit Care Med 2007;35(5):1290-5

Bajwa E, Boyce P, Januzzi J, Gong M, Thompson BT, Christiani D, Biomarker evidence of myocardial cell injury is associated with mortality in Acute Respiratory Distress Syndrome. Crit Care Med 2007;35(11):2484-90.

Bajwa E, Januzzi J, Gong M., Thompson BT, Christiani D. Prognostic value of plasma NT-proBNP levels in the Acute Respiratory Distress Syndrome. Crit Care Med 2008;36(8):2322-7.

Bajwa E, Khan UA, Januzzi JL, Gong MN, Thompson BT, Christiani DC. Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest. 2009 Aug;136(2):471-80. Epub 2009 May 1.

Gong MN, Bajwa E, Thompson BT, Christiani DC. Body mass index is associated with the development of acute respiratory distress syndrome. Thorax. 2010 Jan;65(1):44-50. Epub 2009 Sep 21.

Sheu CC, Gong MN, Zhai R, Bajwa E, Chen F, Thompson BT, Christiani DC. The influence of infection sites on development and mortality of ARDS. Intensive Care Med. 2010 Jun;36(6):963-70. Epub 2010 Mar 13.

Sheu CC, Gong MN, Zhai R, Chen F, Bajwa E, Clardy PF, Gallagher DC, Thompson BT, Christiani DC. Clinical Characteristics and Outcomes of Sepsis-Related vs. Non-Sepsis-Related Acute Respiratory Distress Syndrome. Chest. 2010 May 27. [Epub ahead of print]

Pulmonary and Critical Care
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-726-1721